Biologically active sphingolipids in cancer pathogenesis and treatment.
Ogretmen
Besim
B
Department of Biochemistry and Molecular Biology, and Hollings Cancer Center, 173 Ashley Avenue, Charleston, South Carolina 29425, USA.
Hannun
Yusuf A
YA
D017209:Apoptosis; D002455:Cell Division; D002518:Ceramides / Q000494:pharmacology*; D006801:Humans; D008246:Lysophospholipids / Q000494:pharmacology*; D009369:Neoplasms / Q000188:drug therapy* / Q000503:physiopathology*; D013107:Sphingolipids / Q000378:metabolism* / Q000494:pharmacology*; D013110:Sphingosine / Q000031:analogs & derivatives / Q000494:pharmacology*
D002518:Ceramides; D008246:Lysophospholipids; D013107:Sphingolipids; C060506:sphingosine 1-phosphate; D013110:Sphingosine